cGMP-dependent protein kinase inhibitors block light-induced phase advances of circadian rhythms in vivo.
Synchronization of circadian rhythms is thought to be accomplished primarily through daily phase delays and advances of the endogenous circadian clock that, in mammals, is located in the hypothalamic suprachiasmatic nucleus (SCN). In the SCN, numerous second messenger pathways may participate in photic signal transduction. In these studies, the involvement of cyclic nucleotide-dependent kinases was examined in vivo using inhibitors of adenosine 3',5'-cyclic monophosphate (cAMP)- and guanosine 3',5'-cyclic monophosphate (cGMP)-dependent kinase (PKA and PKG, respectively). In constant dark, selective and nonselective inhibitors of PKG injected near the SCN of hamsters had no effect on phase delays produced by light pulses given in the early subjective night (early in the animals' active period) but significantly attenuated phase advances induced late in the subjective night. PKA inhibition had no effect at either time point. In addition, cGMP agonists had no effect on rhythmicity in the absence of light. The results suggest that PKG activity is necessary, but not sufficient, for normal photic responsiveness and that PKA activity is not required. The phase dependence of the effect of PKG inhibition supports the notion that photic entrainment is influenced by biochemical pathways that differentially regulate sensitivity in a phase-dependent manner.
Mathur
A
A
Department of Psychology, University of Toronto, Ontario, Canada.
Golombek
D A
DA
Ralph
M R
MR
D000470:Alkaloids / Q000494:pharmacology; D000818:Animals; D002227:Carbazoles; D002940:Circadian Rhythm / Q000187:drug effects* / Q000528:radiation effects*; D006224:Cricetinae; D006152:Cyclic GMP / Q000031:analogs & derivatives / Q000494:pharmacology; D017869:Cyclic GMP-Dependent Protein Kinases / Q000037:antagonists & inhibitors*; D007211:Indoles; D007546:Isoquinolines / Q000494:pharmacology; D008027:Light; D008297:Male; D008647:Mesocricetus; D009043:Motor Activity / Q000187:drug effects
D000470:Alkaloids; D002227:Carbazoles; D007211:Indoles; D007546:Isoquinolines; C073601:KT 5823; C016276:8-bromocyclic GMP; C053177:N-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide; D017869:Cyclic GMP-Dependent Protein Kinases; D006152:Cyclic GMP